Hello, Thanks for signing up for MarketBeat Daily Ratings—we’re excited to have you on board. Every weekday, you’ll get a curated summary of new “Buy” and “Sell” ratings from Wall Street’s top-rated analysts, the latest stock news, and bonus investing content—all delivered straight to your inbox. You’re just two quick steps away from completing your sign-up: 1. Make sure our emails go to your inbox Gmail users:
Mobile: Tap the three dots (…) in the top right and select Move to Inbox or Move to Primary
Desktop: Click the folder icon at the top and select Move to Inbox or Primary Apple Mail users:
Tap our email address at the top (next to From: on mobile), then select Add to VIP Other providers:
Reply to this message and add newsletters@analystratings.net to your contacts 2. Confirm your subscription Click this link to confirm your subscription. This verifies your account and ensures you receive your newsletters without interruption instead of getting stuck in your spam filter. Confirm your subscription here. After you confirm, feel free to download our popular free report, "7 Stocks to Buy and Hold Forever" with this link. Thanks again for subscribing—we look forward to being part of your investing journey. 
Matthew Paulson
Founder and CEO, MarketBeat. P.S. If you didn’t mean to subscribe, no problem—you can unsubscribe here.
Today's Exclusive Article CooperCompanies Insiders Buy as Rebound Setup FormsWritten by Thomas Hughes. Published: 3/9/2026. 
Key Points - CooperCompanies insiders bought shares in late 2025, highlighting a value opportunity that has reemerged in early 2026.
- Analysts and institutions are accumulating this stock, and have its price set up to reverse course as the year progresses.
- Capital returns, specifically share buybacks, provide leverage and increase value for investors, underpinning a robust outlook for a stock price rebound.
- Special Report: Elon Musk's $1 Quadrillion AI IPO
CooperCompanies (NASDAQ: COO) insiders signaled confidence in the company's growth outlook by buying shares in December, extending a trend that began the month before. Insiders — including the CEO, several directors and other C-suite executives — bought shares when the stock was at long-term lows, helping catalyze a rebound. But the story may not be over. COO pulled back in early March after an otherwise healthy earnings report, offering another opportunity to get into the stock. Headwinds remain, but the long-term outlook is constructive, supported by growth, profitability and meaningful capital returns. I've worked for the CIA, personally met four US presidents, and spent 45 years studying the markets—calling Black Monday six weeks before it happened, predicting the fall of the Berlin Wall, and pinpointing the exact bottom in 2009. But what I'm about to share with you is the boldest prediction of my career. After meeting Elon Musk face-to-face at a private gathering of Wall Street elites and months of my own research, I'm now staking my reputation on one date: March 26, 2026. That's when I believe Elon will announce the SpaceX IPO—what Bloomberg is calling the biggest listing of all time. I have found an access code that lets you grab a pre-IPO stake before it happens, but in 72 hours, your window could close. Click here to see how to claim your SpaceX access code CooperCompanies is well positioned to drive growth and cash flow as a leading consumer-focused medical device company. It sells products through two main lines: vision and women's/family health. The vision segment is best known for its contact lenses, frequently ranked among the top three globally. The women's health division is a major player in contraception, fertility and gynecology. Long-term forecasts point to mid- to moderate single-digit revenue growth through the middle of the next decade, with earnings growth running slightly ahead. Capital Returns Keep Analysts and Institutions Interested in COO Stock CooperCompanies' capital return program consists entirely of share repurchases, but the buybacks are substantial and sustainable, enhancing returns for shareholders. Fiscal Q1 2026 buyback activity, together with repurchases in prior quarters, reduced share count by roughly 2.25% year over year, and the program is expected to continue in coming quarters. The balance sheet presents no red flags and provides additional reasons to consider the stock. Quarter-end highlights include higher cash and assets, reduced debt and liabilities, and increased equity despite aggressive buybacks. Equity rose about 1.5%, and leverage remains very low, giving the company flexibility to execute its strategy: expand product lines, develop new offerings and pursue targeted acquisitions. Historically, CooperCompanies has selectively acquired high-quality, niche products that complement its core segments. Analyst coverage reflects confidence in the business. The consensus sits at a Moderate Buy rating, with a bullish tilt: roughly 50% Buy and 49% Hold (one Sell rating is recorded). Coverage has increased on a trailing-12-month basis, and price targets firmed after the March earnings update. As of early March, consensus implies about 25% upside from recent lows; a move toward the $90 consensus target would set a long-term high, clear key resistance and signal a fuller reversal. Technical Reversal Is in Play: Head-and-Shoulders Reversal Underway While the pattern is not complete, COO's price action and fundamentals suggest a head-and-shoulders reversal is forming. The first shoulder came together in early 2025, the head emerged mid-year, and the second shoulder appears to be developing now. There is a risk the market could move lower and test supports around $70 or $65, but that scenario seems less likely given the company's cash flow profile and capital return program. Institutional trends add to the positive case. Holdings remain relatively light at about 25%, but institutions are accumulating shares and activity is increasing. Selling has picked up alongside buying — which could keep volatility elevated — but accumulation at the institutional level is a constructive sign. One potential catalyst to reduce uncertainty and boost appetite is the conclusion of the strategic review begun last year; its outcome could reinvigorate investor interest. CooperCompanies Retreats After Solid Report CooperCompanies delivered a solid Q1, with both revenue and adjusted earnings beating consensus. A modest gross margin contraction — partly due to tariffs — was largely offset by operational improvements and discipline, resulting in expanded profit margins. Adjusted earnings grew nearly 20% for the quarter and appear poised to continue outpacing estimates as the year progresses. Management raised guidance compared with prior guidance, which remains deliberately cautious. Momentum in product lines such as MyDay and MiSight, which slow the progression of myopia in children, supports the outlook. 
| 
Post a Comment
Post a Comment